FdaApplication

ANDA 076908

Back to search

Identifiers

Properties

PropertyValue
applicant_nameCHARTWELL RX SCIENCES LLC
application_typeANDA
approval_date2012-03-12

Products (3)

ProductActive ingredientStrengthDosage form
RISPERIDONERISPERIDONE2MGTABLET, ORALLY DISINTEGRATING;ORAL
RISPERIDONERISPERIDONE0.5MGTABLET, ORALLY DISINTEGRATING;ORAL
RISPERIDONERISPERIDONE1MGTABLET, ORALLY DISINTEGRATING;ORAL

3 products